Intelligence Β· Patent portfolio
Kura Oncology Patents
Full USPTO pharma patent portfolio for Kura Oncology β grant dates, expiration, and drug cross-links.
- Patents
- 132
- Expiring β€24m
- 1
Quick answer
Kura Oncology has 132 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months β use filters for patent-cliff planning.
-
US 12410184
Crystalline forms of a menin inhibitor
granted -
US 12377026
Dental adhesive material kit
granted -
US 12358210
Resin composition for stereolithography
granted -
US 12344691
Resin composition for stereolithography
granted -
US 12214061
Adhesive composition for dental use
granted -
US 12208148
Dental restorative curable composition
granted -
US 12145888
Zirconia molded body and pre-sintered body capable of being sintered in short time
granted -
US 12138325
Dental composition
granted -
US 12115031
Dental mill blank and dental prosthesis
granted -
US 12030970
Curable composition and stereolithographic resin composition comprising same
granted -
US 12018011
Macrocyclic compounds and compositions, and methods of preparing and using the same
granted -
US 11981763
Resin composition for stereolithographic modeling
granted -
US 11944627
Methods for treating hematological malignancies and Ewing's sarcoma
granted -
US 11890359
Zirconia composition, partially sintered material and sintered material and methods for production thereof, and laminate
granted -
US 11813341
Dental product with enhanced toughness
granted -
US 11802237
Method for producing powder containing zirconia particles and fluorescent agent
granted -
US 11707346
Dental mill blank and method for producing same
granted -
US 11672774
Methods of treating squamous cell carcinomas with farnesyltransferase inhibitors
granted -
US 11668704
Degradation preventing means for immunoassay reagent containing insoluble carrier particles
granted -
US 11649251
Substituted inhibitors of menin-MLL and methods of use
granted -
US 11607370
Dental composition
granted -
US 11547639
Dental composition containing platinum nanoparticles
granted -
US 11541045
Methods of treating cancer with farnesyltransferase inhibitors
granted -
US 11484477
Dental adhesive material kit
granted -
US 11485813
Resin composition for stereolithography
granted -
US 11472729
Silicate glass and dental product
granted -
US 11452674
Non-solvent dental adhesive composition
granted -
US 11453785
Method for producing surface-treated colored inorganic particles
granted -
US 11401461
Zirconia sintered body containing fluorescent agent
granted -
US 11400030
Two-paste dental curable composition
granted -
US 11365280
Photocurable resin composition
granted -
US 11304879
Adhesive composition for dental use
granted -
US 11291663
Methods of treating cancer with farnesyltransferase inhibitors
granted -
US 11207314
Methods of treating cancer patients with farnesyltransferase inhibitors
granted -
US 11179486
Wet wiper
granted -
US 11173100
Multi-part dental cement
granted -
US 11124839
Methods of treating cancer patients with farnesyltransferase inhibitors
granted -
US 11045425
Method of encapsulating pancreatic islet cells introduced to siRNA against PHLDA3
granted -
US 11033467
Zirconia composition, partially sintered material and sintered material and methods for production thereof, and laminate
granted -
US 10987281
Self-adhesive dental composite resin
granted -
US 10980793
Methods of treating cancer with farnesyltransferase inhibitors
granted -
US 10806730
Methods of treating cancer with farnesyltransferase inhibitors
granted -
US 10786435
Composition for optical three-dimensional modeling
granted -
US 10603250
One-pack type dentinal tubule occlusion material
granted -
US 10478385
Dental adhesive material kit
granted -
US 10471055
Methods of treating cancer patients with farnesyltransferase inhibitors
granted -
US 10456333
Dental adhesive
granted -
US 10426712
Dental polymerizable composition
granted
Frequently asked questions
How many patents does Kura Oncology have?
132 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Kura Oncology patents expire?
1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory